Heading to EADV!

In two weeks, our Thalocan Research Innovations CEO Eric Zudak will be attending the 2026 EADV Congress in Vienna.  The congress showcases the latest science, research, and best practices across all areas of dermato-venereology, offering hands-on workshops, sub-specialty sessions, and industry presentations that cover the full spectrum of dermatology and venereology topics.

At Thalocan, we are proud to be a part of the community providing customized training, cutting edge technology and revolutionizing the clinical assessment of dermatological diseases. Learn more about EADV at https://eadv.org/congress/ and learn more about us at www.thalocan.com